VCIG Secures Government and Enterprise Engagements Following ASEAN AI Summit Showcase of Full-Stack Sovereign AI and Cybersecurity Technologies

VCIG Secures Government and Enterprise Engagements Following ASEAN AI Summit Showcase of Full-Stack Sovereign AI and Cybersecurity Technologies VCI Global Advances Regional Expansion with Signed Deals and National-Level AI Initiatives Following ASEAN AI Summit GlobeNewswire August 15, 2025 KUALA LUMPUR, Malaysia, Aug. 15, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or […]

Dunwoody College of Technology Names Amalan Pulendran as Director of Computer Technology

Longtime faculty member to lead curriculum innovation and industry partnerships Dunwoody College of Technologyis proud to announce Amalan Pulendran as its new Director of Computer Technology. A veteran educator and leader within the College, Pulendran brings over a decade of teaching, curriculum innovation, and operational leadership to the role. Pulendran's appointment marks a natural progression

In May, the Percentage of Patients with a Telehealth Claim Increased Nationally and in Every Region

Diabetes Entered Top Five Telehealth Diagnostic Categories in Midwest and West in May for First Time in 2025 In May 2025, the percentage of patients with a telehealth claim increased nationally and in all four US census regions, according to FAIR Health's Monthly Telehealth Regional Tracker. Nationally, that percentage increased from 14.2 percent of patients

re:BOND Hair Launches AMINOFIXX™ Daily Miracle Bond³ Building Spray – Advanced Solution for Hair Damage at the Molecular Level

re:BOND Molecular Hair Science is excited to announce the launch of AMINOFIXX™ Daily Miracle Bond³ Building Spray, a revolutionary leave-in spray treatment designed to repair and protect hair from the cumulative damage caused by chemical, thermal, mechanical, and environmental stressors. Hair's Cell Membrane Complex (CMC) plays a critical role in maintaining hair structure, strength, and

Ondas Appoints Dr. Irit Idan to Advisory Board of Ondas Autonomous Systems

Former Rafael Advanced Systems Executive and SoftBank Vision Fund Advisor Brings Deep Expertise in AI, Robotics, Autonomous Systems, and Defense Innovation Dr. Idan’s appointment supports OAS’ broader growth plan and long-term strategy to enhance its product roadmap, strengthen customer relationships, and accelerate global adoption of its Optimus and Iron Drone Raider platforms BOSTON, MA /

Clinical Trial Application Success: CMC and Regulatory Insights from the US to Europe, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insights on optimizing Investigational New Drug (IND) and Clinical Trial Application (CTA) submissions through aligned chemistry, manufacturing and controls (CMC) and regulatory strategies. Attendees will learn about key CMC requirements for early-phase development and strategies to leverage accelerated CMC programs. The featured speakers will discuss EMA and FDA clinical trial

Daniel W. Schatz, M.D. Now Offering patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Daniel W. Schatz, M.D,Internal medicine physician from Medical Clinic of Houston, gives patients the optionfor more time, service and exclusive one-to-one connectivity Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, announces today that Medical Clinic of Houston (MCH) internal medicine physician Daniel W. Schatz, M.D., is the latest physician to now

Patrick Industries, Inc. Declares Quarterly Cash Dividend

Patrick Industries, Inc. (NASDAQ: PATK) (“Patrick” or the “Company”) today announced that on August 14, 2025, its Board of Directors (the “Board”) declared a quarterly cash dividend on its common stock of $0.40 per share. The dividend is payable on September 8, 2025 to shareholders of record at the close of business on August 25,

Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer SeekĀ®

Caris Life Sciences®(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in Oncotarget validating the analytical and clinical performance of MI Cancer Seek®. This FDA-approved assay is used as a companion diagnostic (CDx) to identify cancer patients who may benefit from targeted therapies. It includes one pan-cancer

Tie “James” Li, Chairman of NMHI, To Speak at XRP Seoul 2025 Global Conference

Tie “James” Li, Chairman and CEO of Nature's Miracle Holding Inc. (OTCQB:NMHI) will attend the XRP Seoul 2025 Global Conference as a keynote speaker on September 21, 2025. https://mma.prnewswire.com/media/2719445/NMHI_Logo.jpg XRP SEOUL 2025 hosted by XRPL Korea is a global conference bringing together XRP holders, developers, and ecosystem projects from around the world. Taking place on

Scroll to Top